CDEK by Data4ThePeople

Sign in Sign up

← All organizations

QBE Europe SA/NV

For profitWebsite ↗

Also known as: QBE Europe SA/NV

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2019

Timeline

2010s

Feb 12, 2018
QBE Europe SA/NV— Founded

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

levosimendan

Indications

Studied for

Cardiac Output, Low

Recent trials (1)

NCT04179604CollaboratorPhase 2/Phase 3Dec 31, 2019

Details

Founded: London, GB Feb 12, 2018
Last known activity: Dec 31, 2019